Home > Insider Trading > Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc (JAZZ)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2023 Earnings Call Transcript

Operator: Good afternoon. My name is Krista, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals Third Quarter 2023 Earnings Call.

Keep Reading →

November 9th, 2023 - News Transcripts

10 Stocks That Will Skyrocket

Investors remain anxious about the Fed’s next move and the upcoming policy decision as they continue to process consumer data to get hints on inflation’s trajectory.

Keep Reading →

October 31st, 2023 - Hedge Funds News

5 Most Undervalued Pharma Stocks To Buy According To Analysts

In this piece, we will take a look at the five most undervalued pharmaceutical stocks to buy according to analysts.

Keep Reading →

October 30th, 2023 - Hedge Funds News

11 Best Long-Term Stocks To Buy For High Returns

In this piece, we will take a look at the 11 best long term stocks to buy for high returns.

Keep Reading →

October 30th, 2023 - Hedge Funds News

11 Best Immunotherapy Stocks To Buy Now

In this article, we discuss 11 of the best immunotherapy stocks to buy now.

Keep Reading →

October 30th, 2023 - Hedge Funds News

Top 30 Oncology Companies in the World

In this article, we shall cover the top 30 oncology companies in the world.

Keep Reading →

October 13th, 2023 - Business Hedge Funds Lists News

What Makes Jazz Pharmaceuticals plc (JAZZ) a Prospective Investment Bet?

Aristotle Capital Management, LLC, an investment management company, released its “Global Equity Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 13th, 2023 - Hedge Fund Investor Letters News

14 Best Cancer Stocks To Buy Now

The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for a growing number of patients.

Keep Reading →

October 9th, 2023 - Hedge Funds News

15 Stocks Billionaire Seth Klarman Likes the Most Now

In this article, we looked at what billionaire Seth Klarman thinks about the stock market outlook, his investing principles, and what he recommends to investors.

Keep Reading →

October 4th, 2023 - Hedge Fund Analysis News